A replay of the call will be available approximately one hour after the end of the call through May 6, 2018. The replay can be accessed via Sigma Labs' website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international) or Canada Toll Free at 855-669-9658. The replay conference ID number is 10118960. The webcast replay will be available through July 9, 2018.
About Sigma Labs, Inc.
Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at
www.sigmalabsinc.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on March 31, 2017 and which may be viewed at
http://www.sec.gov.
Investor Relations Contact:
Bret Shapiro
Managing Director
CORE IR
561-479-8566
brets@coreir.com
Sigma Labs, Inc. | |||||||
Condensed Balance Sheets | |||||||
(Unaudited) | |||||||
December 31, 2017 | December 31, 2016 | ||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash | $ | 1,515,674 | $ | 398,391 | |||
Accounts Receivable, net | 104,538 | 288,236 | |||||
Note Receivable, net | 788,500 | - | |||||
Inventory | 192,705 | 187,241 | |||||
Prepaid Expenses | 55,278 | 36,056 | |||||
Total Current Assets | 2,656,695 | 909,924 | |||||
Other Assets: | |||||||
Property and Equipment, net | 411,643 | 564,933 | |||||
Intangible Assets, net | 294,396 | 226,450 | |||||
Investment in Joint Venture | 500 | 500 | |||||
Prepaid Stock Compensation | 31,576 | 167,562 | |||||
Total Other Assets | 738,115 | 959,445 | |||||
TOTAL ASSETS | $ | 3,394,810 | $ | 1,869,369 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current Liabilities: | |||||||
Accounts Payable | 100,884 | 112,175 | |||||
Notes Payable, net of original issue discount of $0 at | |||||||
December 31, 2017 and net of original issue discount of | |||||||
$69,703 and net of debt discount $358,280 at December 31, | |||||||
2016 | 100,000 | 561,834 | |||||
Deferred Revenue | 108,680 | 76,315 | |||||
Accrued Expenses | 146,330 | 121,801 | |||||
Total Current Liabilities | 455,894 | 872,125 | |||||
Long-Term Liabilities | |||||||
Derivative Liability | - | 93,206 | |||||
Total Long-Term Liability | - | 93,206 | |||||
TOTAL LIABILITIES | 455,894 | 965,331 | |||||
Stockholders' Equity | |||||||
Preferred Stock, $0.001 par; 10,000,000 shares authorized; | |||||||
None issued and outstanding | - | - | |||||
Common Stock, $0.001 par; 7,500,000 shares authorized; | |||||||
4,978,929 and 3,133,789 issued and outstanding at | |||||||
December 31, 2017 and December 31, 2016, respectively | 4,979 | 3,135 | |||||
Additional Paid-In Capital | 17,345,407 | 10,734,857 | |||||
Accumulated Deficit | (14,411,470 | ) | (9,833,954 | ) | |||
Total Stockholders' Equity | 2,938,916 | 904,038 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 3,394,810 | $ | 1,869,369 | |||